Evidence map›Paper›PMID 41368443›Full record

ArticleFrontiers in cellular neuroscience2025

Correction: CRISPR-Cas9: bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders.

Anas Shamsi, Mohammed Alrouji, Othman AlOmeir, Syed Tasqeruddin, Khuzin Dinislam, Azna Zuberi

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Anas ShamsiCentre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Mohammed AlroujiDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
Othman AlOmeirDepartment of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.
Syed TasqeruddinDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Khuzin DinislamDepartment of General Chemistry, Bashkir State Medical University, Ufa, Russia.
Azna ZuberiDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fncel.2025.1681891.].

Indexed as

agingAlzheimer's diseaseamyotrophic lateral sclerosis (ALS)CRISPR-Cas9gene editingHuntington's diseaseneurodegenerative diseasesParkinson's disease

Identifiers

PMID41368443
PMCPMC12683659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.